BiochemistrybioRxivPreprint
Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro
Y. Chen, W.-H. Yang, L.-M. Huang…·M.-C. Hung
This study identifies tafenoquine as an inhibitor of SARS-CoV-2 main protease, showing it reduces protease activity and inhibits viral infection in vitro.
DOI 10.1101/2020.08.14.250258